NCT05814341View on ClinicalTrials.gov

Citrate Anticoagulation in Renal Replacement Therapy: Impact of a High Post-filter Calcium Target on Efficacy

PHASE3CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2024

Conditions

Renal Replacement Therapy

Interventions

DRUG

Citrate

Comparison of two dosage adjustment protocols for medication according to different post-filter iCa targets

Trial Locations (1)

75013

Hospital Pitie Salpetriere, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05814341 - Citrate Anticoagulation in Renal Replacement Therapy: Impact of a High Post-filter Calcium Target on Efficacy | Biotech Hunter | Biotech Hunter